Following adults with inflammatory bowel disease through a research cohort and biobank
Collects samples from adults with active inflammatory bowel disease for a research biobank.
Key facts
- Who runs it
- Nantes University Hospital
- Where
- Nantes, FranceSee the 3 sites
- Trial code
- Registry title
- Inflammatory Bowel Disease Cohort in Nantes
- Status
- Recruiting
- People taking part
- 360 people, planned
- Started
- 4 Feb 2025
- Expected to end
- Feb 2031
- Type of study
- Observational
- Treatments tested
- Collection of biological samples
- Record updated
- 10 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a confirmed inflammatory bowel disease that is active and needs surgery or an endoscopy. They also agree to give biological samples.
- Age
- Over 18 years
- Sex
- All
- Disease stage
- Active disease that needs surgery or endoscopy, done at diagnosis or before starting a new treatment.
Main reasons for not taking part
- Refuses to take part in the cohort
- Disease is quiet (not active) at the start
- Cannot have general anaesthesia
- Vulnerable people (under court protection, curators, guardians)
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients over 18 years of age
- Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis
- Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy
- Patients who have given written consent to participate in the study and to keep biological samples for research purposes
Who cannot take part
- Patients with chronic inflammatory bowel disease quiescent at inclusion
- Patients refusing to participate in the cohort
- Patients with a contraindication to general anaesthesia
- Vulnerable patients (under court protection, curators, guardians)
Where in France
- CHU de NantesNantes, FranceContact: Catherine Le Berre, MDTaking people
- Clinique Jules VerneNantes, FranceContact: Mathurin FLAMANT, MDNot yet recruiting
- Hôpital Privé du ConfluentNantes, FranceContact: Caroline TRANG, MDNot yet recruiting
About the trial
What the trial wants to find out
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
The group in the trial
- Patients
Patients of both sexes, over 18 years of age, with an established diagnosis of IBD (Crohn's desease, ulcerative colitis, unclassified IBD or chronic pouchitis) will be eligible for inclusion in a consultation to schedule surgery or colonoscopy for disease relapse (at diagnosis or prior to initiation of treatment), irrespective of treatment received
Treatment: Collection of biological samples
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Cohorte Nantaise de Maladies Inflammatoires Chroniques Intestinales
- Plain-language title
- Following adults with inflammatory bowel disease through a research cohort and biobankGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 10 February 2025